Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.
作者信息
Zahr Rima S, Hankins Jane S, Kang Guolian, Li Chen, Wang Winfred C, Lebensburger Jeffrey, Estepp Jeremie H
机构信息
Division of Pediatric Nephrology and Hypertension, University of Tennessee Health Science Center, Memphis, Tennessee.
Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee.
出版信息
Am J Hematol. 2019 Jan;94(1):E27-E29. doi: 10.1002/ajh.25329. Epub 2018 Nov 29.
Abstract
摘要
相似文献
1
Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia.羟基脲可预防镰状细胞贫血患儿蛋白尿的发生和进展。
Am J Hematol. 2019 Jan;94(1):E27-E29. doi: 10.1002/ajh.25329. Epub 2018 Nov 29.
2
Hydroxyurea Improves Oxygen Saturation in Children With Sickle Cell Disease.羟基脲可提高镰状细胞病患儿的血氧饱和度。
J Pediatr Hematol Oncol. 2015 Apr;37(3):242-3. doi: 10.1097/MPH.0000000000000251.
3
Hydroxyurea use among children with sickle cell anemia.羟基脲在镰状细胞贫血患儿中的应用。
Pediatr Blood Cancer. 2019 Jun;66(6):e27721. doi: 10.1002/pbc.27721. Epub 2019 Mar 22.
4
Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.非洲镰状细胞贫血的羟基脲治疗：注意差距。
Lancet Glob Health. 2015 Mar;3(3):e124-5. doi: 10.1016/S2214-109X(14)70371-7.
5
Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease.羟基脲疗法对镰状细胞病患儿静息能量消耗的影响。
J Pediatr Hematol Oncol. 2001 Dec;23(9):604-8. doi: 10.1097/00043426-200112000-00010.
6
Increasing hydroxyurea use in children with sickle cell disease at Kamuzu Central Hospital, Malawi.在马拉维的卡穆祖中央医院，镰状细胞病患儿使用羟基脲的情况日益增多。
Blood Adv. 2018 Nov 30;2(Suppl 1):30-32. doi: 10.1182/bloodadvances.2018GS110347.
7
Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.在尼日利亚北部的三个州，约4万名镰状细胞贫血患儿需要接受经颅多普勒超声（TCD）筛查，并使用羟基脲进行治疗以预防中风。
Am J Hematol. 2019 Nov;94(11):E305-E307. doi: 10.1002/ajh.25616. Epub 2019 Sep 11.
8
Hydroxyurea for ALL children with sickle cell anemia: What can we learn from Africa?羟基脲用于所有镰状细胞贫血儿童：我们能从非洲学到什么？
Pediatr Blood Cancer. 2020 Apr;67(4):e28164. doi: 10.1002/pbc.28164. Epub 2020 Jan 11.
9
Expanding the role of hydroxyurea in children with sickle cell disease.扩大羟基脲在镰状细胞病患儿中的作用。
J Pediatr. 2004 Sep;145(3):287-8. doi: 10.1016/j.jpeds.2004.06.032.
10
Hydroxyurea Initiation Among Children With Sickle Cell Anemia.镰状细胞贫血患儿开始使用羟基脲治疗的情况。
Clin Pediatr (Phila). 2019 Nov;58(13):1394-1400. doi: 10.1177/0009922819850476. Epub 2019 May 21.
引用本文的文献
1
Development of Polygenic Risk Score for Persistent Albuminuria in Children and Adults With Sickle Cell Anemia.镰状细胞贫血儿童和成人持续性蛋白尿多基因风险评分的开发
Am J Hematol. 2025 Jun;100(6):1019-1028. doi: 10.1002/ajh.27678. Epub 2025 Apr 5.
2
Hydroxyurea and Regression of Sickle Cell Nephropathy: Open Clinical Trial in a Pediatric Population in Democratic Republic of Congo.羟基脲与镰状细胞肾病的病情缓解：刚果民主共和国儿科人群的开放临床试验
Kidney360. 2025 Apr 3;6(8):1394-1403. doi: 10.34067/KID.0000000805.
3
Factors Associated with Microalbuminuria among Children with Sickle Cell Disease in a Tertiary Centre in South-South Nigeria.尼日利亚南南地区一家三级中心镰状细胞病患儿微量白蛋白尿的相关因素
Niger Med J. 2025 Jan 10;65(6):885-898. doi: 10.60787/nmj-v65i6.493. eCollection 2024 Nov-Dec.
4
Hydroxyurea in the sickle cell disease modern era.羟基脲在镰状细胞病时代。
Expert Rev Clin Pharmacol. 2024 Sep;17(9):777-791. doi: 10.1080/17512433.2024.2390915. Epub 2024 Aug 20.
5
Natural history of albuminuria in a large cohort of children and adolescents with sickle cell anemia from Brazil.巴西一大群镰状细胞贫血儿童和青少年白蛋白尿的自然病史。
Blood Adv. 2024 Jan 23;8(2):365-368. doi: 10.1182/bloodadvances.2023011765.
6
Sickle Cell Disease and CKD: An Update.镰状细胞病与慢性肾脏病：最新进展。
Am J Nephrol. 2024;55(1):56-71. doi: 10.1159/000534865. Epub 2023 Oct 27.
7
Kidney failure outcomes in children and young adults with sickle cell disease in the United States Renal Data System.美国肾脏病数据系统中儿童和青年镰状细胞病患者的肾脏衰竭结局。
Pediatr Nephrol. 2024 Feb;39(2):619-623. doi: 10.1007/s00467-023-06136-0. Epub 2023 Sep 1.
8
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
9
Natural history and variability in albuminuria in pediatric and murine sickle cell anemia.儿童和鼠类镰状细胞贫血中白蛋白尿的自然史和变异性。
Blood Adv. 2023 Nov 28;7(22):6850-6858. doi: 10.1182/bloodadvances.2023010101.
10
End Stage Kidney Disease Outcomes in Children and Young Adults with Sickle Cell Disease in the United States Renal Data System.美国肾脏数据系统中镰状细胞病儿童和青年的终末期肾病结局
Res Sq. 2023 May 26:rs.3.rs-2977181. doi: 10.21203/rs.3.rs-2977181/v1.
本文引用的文献
1
Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.镰状细胞临床研究和干预计划 (SCCRIP)：一项从儿科阶段到成年期镰状细胞病进展的寿命队列研究。
Pediatr Blood Cancer. 2018 Sep;65(9):e27228. doi: 10.1002/pbc.27228. Epub 2018 May 24.
2
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.镰状细胞病的管理：专家小组成员 2014 年循证报告的总结。
JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517.
3
Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia.羟基脲治疗可降低镰状细胞贫血患儿的肾小球高滤过。
Am J Hematol. 2013 Feb;88(2):116-9. doi: 10.1002/ajh.23365. Epub 2012 Dec 17.
4
Chronic kidney disease and albuminuria in children with sickle cell disease.儿童镰状细胞病的慢性肾脏病和白蛋白尿。
Clin J Am Soc Nephrol. 2011 Nov;6(11):2628-33. doi: 10.2215/CJN.01600211. Epub 2011 Sep 22.
5
Protective role of hemoglobin and fetal hemoglobin in early kidney disease for children with sickle cell anemia.血红蛋白和胎儿血红蛋白对镰状细胞贫血患儿早期肾脏病的保护作用。
Am J Hematol. 2011 May;86(5):430-2. doi: 10.1002/ajh.21994.
Zotero 插件